Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis

Vector-Borne and Zoonotic Diseases

Volumn 6, Issue 4, 2006, Pages 388-394

  Wormser, Gary P ^a   Filozov, Alina ^a   Telford III, Sam R ^b   Utpat, Sandeepa ^a   Kamer, Russell S ^a   Liveris, Dionysios ^a   Wang, Guiqing ^a   Zentmaier, Lois ^a   Schwartz, Ira ^a   Aguero Rosenfeld, Maria E ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antibiotic treatment; Ehrlichiosis; Human granulocytic anaplasmosis; Quinolone; Rickettsia; Tick borne infecion; Tolerance HGA

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; LEVOFLOXACIN; METHYLPREDNISOLONE; OXYGEN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ANAMNESIS; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COLON CANCER; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GRANULOCYTE; HOME OXYGEN THERAPY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPOTHYROIDISM; LABORATORY TEST; LARYNX CANCER; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; SCID MOUSE; TREATMENT DURATION;

AGED; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, SCID; OFLOXACIN; RECURRENCE; TREATMENT OUTCOME;

ANAPLASMA PHAGOCYTOPHILUM; IXODIDA; RICKETTSIA;

EID: 33846496190     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/vbz.2006.6.388     Document Type: Article

References (25)

1. Horowitz, HW, Hsieh, T-C, Aguero-Rosenfeld, ME, et al. Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother 2001; 45:786-788.
2. Maurin, M, Bakken, JS, Dumler, JS. Antibiotic susceptibility of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother 2003; 47:413-415.
3. Klein, MB, Nelson, CM, Goodman, JL. Antibiotic susceptibility of the newly cultured agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifampin. Antimicrob Agents Chemother 1997; 41:76-79.
4. Branger, S, Rolain, JM, Raoult, D. Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR. Antimicrob Agents Chemother 2004; 48:4822-4828.
5. Pan, XS, Ambler, J, Mehtar, S, et al. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40:2321-2326.
6. Maurin, M, Abergel, C, Raoult, D. DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp. Antimicrob Agents Chemother 2001; 45: 2098-2105.
7. Telford, SR, III, Dawson, JE, Katavolos, P, et al. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci USA 1996; 93:6209-14.
8. Aguero-Rosenfeld, ME, Horowitz, HW, Wormser, GP, et al. Human granulocytic ehrlichiosis (HGE): a case series from a single medical center in New York State. Ann Intern Med 1996; 125:904-908.
9. Aguero-Rosenfeld, ME, Kalantarpour, F, Baluch, M, et al. Serology of culture-confirmed cases of human granulocytic ehrlichiosis (HGE). J Clin Microbiol 2000; 38:635-638.
10. Goodman, JL, Nelson, C, Vitale, B, et al. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996; 334:209-215.
11. Sumner, JW, Nicholson, WL, Massung, RF. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol 1997; 35:2087-2092.
12. Heimer, R, Van Andel, A, Wormser, GP, et al. Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. J Clin Microbiol 1997; 35:923-927.
13. Drugeon, HB, Juvin, ME, Bryskier, A. Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin. J Antimicrob Chemother 1999; 43(Suppl C):55-59.
14. Bonacorsi, SP, Scavizzi, MR, Guiyoule, A, et al. Assessment of a fluoroquinolone, three b-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother 1994; 38:481-486.
15. Wolfson, JS, Hooper, DC, Shih, DJ, et al. Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones. Antimicrob Agents Chemother 1989; 33:705-709.
16. Goldman, JD, White, DG, Levy, SB. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid killing by fluoroquinolones. Antimicrob Agents Chemother 1996; 40:1266-1269.
17. Black, DS, Irwin, B, Moyed, HS. Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol 1994; 176: 4081-4091.
18. Wolfson, J, Hooper, D, McHugh, G, et al. Mutations of Escherichia coli k-12 exhibiting reduced killing by both quinolone and beta-lactam antibiotics. Antimicrob Agents Chemother 1990; 34:1938-1943.
19. Webster, P, Ijdo, JW, Chicoine, M, et al. The agent of human granulocytic ehrlichiosis resides in an endosomal compartment. J Clin Invest 1998; 101:1932-1941.
20. Mott, J, Barnewell, R, Rikihisa, Y. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect Immun 1999; 67:1368-1378.
21. Blouin, EF, Kocan, KM, de la Fuente, J, et al. Effect of tetracycline on development of Anaplasma marginale in cultured Ixodes scapularis cells. Vet Parasitol 2002; 107: 115-126.
22. Wells, MY, Rikihisa, Y. Lack of lysosomal fusion with phagosomes containing Ehrlichia risticii in P388D1 cells: abrogation of inhibition with oxytetracycline. Infect Immun 1988; 56:3209-3215.
23. Horowitz, HW, Aguero-Rosenfeld, M, Dumler, JS, et al. Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med 1998; 129:461-463.
24. Krause, PJ, Corrow, CL, Bakken, JS. Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics 2003; 112:e252-e253.
25. Buitrago, MI, Ijdo, JW, Rinaudo, P, et al. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis 1998; 27:213-215.